- ►diabetesjournals.org HR Black, B Davis, J Barzilay, C Nwachuku, C … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—In participants with metabolic syndrome, at 4 years of follow-up, the incidence of
newly diagnosed diabetes (fasting glucose ≥126 mg/dl) was 17.1% for chlorthalidone, 16.0%
for amlodipine (P = 0.49, chlorthalidone vs. amlodipine) and 12.6% for lisinopril (P < 0.05, ... Cited by 19 - Related articles - BL Direct - All 7 versions
- ►dislipemias.com.ar [PDF] JT Wright Jr, S Harris-Haywood, S Pressel, … - Archives of Internal …, 2008 - archinte.highwire.org Methods A subgroup analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent
Heart Attack Trial (ALLHAT), a randomized, double-blind hypertension treatment trial of 42 418
participants. We defined MetS as hypertension plus at least 2 of the following: fasting ... Cited by 41 - Related articles - BL Direct - All 6 versions
KF Hilgers, JFE Mann - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA Patients with hypertension and the metabolic syndrome have high risk of suffering from future
cardiovascular and kidney disease. There are no large-scale, randomized trials to establish the
antihypertensive drug of choice for this important group of patients, but several authors ... Cited by 2 - Related articles - All 7 versions
LA Hebert, BH Rovin, CJ Hebert - Nature Clinical Practice Nephrology, 2007 - nature.com Lee A Hebert, MD, is Professor of Internal Medicine and a member of the Nephrology Division
of The Ohio State University. His clinical and research interests are immune mechanisms of kidney
disease, particularly that of systemic lupus erythematosus. These studies are largely ... Cited by 4 - Related articles - BL Direct - All 3 versions
AK Gupta, B Dahlof, J Dobson, PS Sever, H Wedel, … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—NOD was significantly associated with an increase in baseline fasting plasma glucose
(FPG), BMI, serum triglycerides, and systolic blood pressure. In contrast, amlodipine ± perindopril
in comparison with atenolol ± thiazide treatment (hazard ratio 0.66 [95% CI 0.59–0.74]), ... Cited by 5 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org P Verdecchia, F Angeli, G Reboldi - Hypertension, 2007 - Am Heart Assoc In the analysis of the VALUE database, all-cause mortality (HR: 0.61; 95% CI: 0.48 to 0.77) and
cardiac mortality (HR: 0.44; 95% CI: 0.28 to 0.70) were lower, not higher, in the subjects with
NOD than in their nondiabetic counterparts. Despite some obvious caveats, including the ... Cited by 13 - Related articles - All 5 versions
JB Green, MN Feinglos - Current Diabetes Reports, 2007 - Springer Diabetes mellitus and obesity have become increasingly prevalent problems worldwide.
Unfortunately, with tra- ditionally prescribed glucose-lowering medications most individuals with
diagnosed diabetes do not achieve and maintain adequate glycemic control over time; it ... Cited by 3 - Related articles - BL Direct - All 2 versions
M Schachter - The British Journal of Diabetes & Vascular Disease, 2005 - dvd.sagepub.com Page 1. http://dvd.sagepub.com The British Journal of Diabetes & Vascular Disease
DOI: 10.1177/14746514050050060401 2005; 5; 320 British Journal of Diabetes &
Vascular Disease Michael Schachter Review: Blood pressure ... Cited by 4 - Related articles - All 3 versions
W Zidek, J Schrader, S Lüders, S Matthaei, C … - Cardiovascular …, 2008 - cardiab.com The ADaPT investigation ("ACE inhibitor-based versus diuretic-based antihypertensive primary
treatment in patients with pre-diabetes") is a 4-year open, prospective, parallel group phase IV
study. It compares an antihypertensive treatment regimen based on ramipril versus a ... Cited by 5 - Related articles - Cached - All 9 versions
